Ulisse Biomed S.p.A. Price (UBM.MI)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

21,569,800

(167.4618)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
Ulisse Biomed S.p.A.
news-img

Income Statement

Ulisse Biomed S.p.A.

Currency: EUR

YEAR 2018 2019 2020 2021 2022 2023
Revenue
Revenue 76.00

+0%

11,000.00

+14,374%

429,000.00

+3,800%

276,628.00

-36%

138,437.00

-50%

66,208.00

-52%

Cost of Revenue
Cost of Revenue 45,982.00 711,000.00 229,000.00 934,378.00 1,682,825.00 1,615,266.00
Gross Profit
Gross Profit -45,906.00

+0%

-700,000.00

+1,425%

200,000.00

-129%

-657,750.00

-429%

-1,544,388.00

+135%

-1,549,058.00

+0%

Gross Profit Ratio (-604.03%) (-63.64%) (0.47%) (-2.38%) (-11.16%) (-23.40%)
Operating Expenses
Research and Development 0.00 0.00 273,971.00 243,100.00 504,321.00 1,300,321.00
General and Administrative 0.00 0.00 0.00 0.00 0.00 0.00
Selling, General & Admin... 1,415,296.00 189,658.00 -196,973.00 -162,497.00 -348,237.00 609,711.00
Selling & Marketing Exp... 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation and Amortiz... 45,982.00 55,632.00 50,857.00 247,720.00 319,639.00 2,654,340.00
Other Expenses -401,160.00 417,000.00 80,000.00 0.00 0.00 0.00
Total Operating Expenses 1,816,456.00 417,000.00 80,000.00 80,603.00 156,084.00 1,910,032.00
Cost and Exponses 1,862,435.00 1,128,000.00 309,000.00 1,014,980.00 1,838,909.00 3,525,298.00
Operating Income
Operating Income -1,862,440.00

+0%

-1,116,000.00

-40%

120,000.00

-111%

-738,350.00

-715%

-1,700,470.00

+130%

-3,459,090.00

+103%

Operating Income Ratio (-24,505.79%) (-101.45%) (0.28%) (-2.67%) (-12.28%) (-52.25%)
Other Income and Exp...
Interest Income 26.00 0.00 0.00 0.00 48.00 191.00
Interest Expenses 0.00 0.00 0.00 206.00 164.00 139.00
Total Other Income/Exp... -71,048.00 211,433.00 104,000.00 134,751.00 392,725.00 -1,337,757.00
EBITDA
EBITDA -1,601,461.00 -1,043,000.00 275,071.00 -355,673.00 -987,945.00 -2,142,368.00
EBITDA ratio (-23,900.79%) (-96.45%) (0.40%) (-1.77%) (-9.97%) (-32.36%)
Income Before Tax
Income Before Tax -1,933,483.00 -1,098,000.00 224,000.00 -603,599.00 -1,307,745.00 -4,796,847.00
Income Before Tax Ratio (-25,440.57%) (-99.82%) (0.52%) (-2.18%) (-9.45%) (-72.45%)
Income Tax Expense
Income Tax Expense -2.00 -18,000.00 2,000.00 0.00 1.00 0.00
Net Income
Net Income -1,933,483.00

+0%

-1,080,000.00

-44%

222,000.00

-121%

-603,599.00

-372%

-1,307,745.00

+117%

-4,796,847.00

+267%

Net Income Ratio (-25,440.57%) (-98.18%) (0.52%) (-2.18%) (-9.45%) (-72.45%)
Earning Per Share
Basic EPS -0.27 -0.15 0.03 -0.07 -0.16 -0.22
Diluted EPS -0.27 -0.15 0.03 -0.07 -0.16 -0.22
Share Outstanding
Basic Share Outstanding 7,250,000.00 7,250,000.00 7,250,000.00 8,063,750.00 8,064,629.00 21,569,800.00
Diluted Share Outstanding 7,250,000.00 7,250,000.00 7,250,000.00 8,063,750.00 8,064,629.00 21,569,800.00
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation